report cover

Dermatology Drug Market - Global Outlook and Forecast 2022-2028

  • 28 January 2022
  • Life Sciences
  • 65 Pages
  • Report code : 24WT-6805652

Dermatology Drug Market

1 Introduction to Research & Analysis Reports
1.1 Dermatology Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dermatology Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dermatology Drug Overall Market Size
2.1 Global Dermatology Drug Market Size: 2021 VS 2028
2.2 Global Dermatology Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dermatology Drug Players in Global Market
3.2 Top Global Dermatology Drug Companies Ranked by Revenue
3.3 Global Dermatology Drug Revenue by Companies
3.4 Top 3 and Top 5 Dermatology Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dermatology Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dermatology Drug Players in Global Market
3.6.1 List of Global Tier 1 Dermatology Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Dermatology Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Dermatology Drug Market Size Markets, 2021 & 2028
4.1.2 External Use
4.1.3 Oral
4.1.4 Injection
4.2 By Type - Global Dermatology Drug Revenue & Forecasts
4.2.1 By Type - Global Dermatology Drug Revenue, 2017-2022
4.2.2 By Type - Global Dermatology Drug Revenue, 2023-2028
4.2.3 By Type - Global Dermatology Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dermatology Drug Market Size, 2021 & 2028
5.1.2 Psoriasis
5.1.3 Skin Infections
5.1.4 Acne
5.1.5 Dermatitis
5.1.6 Others
5.2 By Application - Global Dermatology Drug Revenue & Forecasts
5.2.1 By Application - Global Dermatology Drug Revenue, 2017-2022
5.2.2 By Application - Global Dermatology Drug Revenue, 2023-2028
5.2.3 By Application - Global Dermatology Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Dermatology Drug Market Size, 2021 & 2028
6.2 By Region - Global Dermatology Drug Revenue & Forecasts
6.2.1 By Region - Global Dermatology Drug Revenue, 2017-2022
6.2.2 By Region - Global Dermatology Drug Revenue, 2023-2028
6.2.3 By Region - Global Dermatology Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Dermatology Drug Revenue, 2017-2028
6.3.2 US Dermatology Drug Market Size, 2017-2028
6.3.3 Canada Dermatology Drug Market Size, 2017-2028
6.3.4 Mexico Dermatology Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Dermatology Drug Revenue, 2017-2028
6.4.2 Germany Dermatology Drug Market Size, 2017-2028
6.4.3 France Dermatology Drug Market Size, 2017-2028
6.4.4 U.K. Dermatology Drug Market Size, 2017-2028
6.4.5 Italy Dermatology Drug Market Size, 2017-2028
6.4.6 Russia Dermatology Drug Market Size, 2017-2028
6.4.7 Nordic Countries Dermatology Drug Market Size, 2017-2028
6.4.8 Benelux Dermatology Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Dermatology Drug Revenue, 2017-2028
6.5.2 China Dermatology Drug Market Size, 2017-2028
6.5.3 Japan Dermatology Drug Market Size, 2017-2028
6.5.4 South Korea Dermatology Drug Market Size, 2017-2028
6.5.5 Southeast Asia Dermatology Drug Market Size, 2017-2028
6.5.6 India Dermatology Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Dermatology Drug Revenue, 2017-2028
6.6.2 Brazil Dermatology Drug Market Size, 2017-2028
6.6.3 Argentina Dermatology Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dermatology Drug Revenue, 2017-2028
6.7.2 Turkey Dermatology Drug Market Size, 2017-2028
6.7.3 Israel Dermatology Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Dermatology Drug Market Size, 2017-2028
6.7.5 UAE Dermatology Drug Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Dermatology Drug Major Product Offerings
7.1.4 AbbVie Dermatology Drug Revenue in Global Market (2017-2022)
7.1.5 AbbVie Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Dermatology Drug Major Product Offerings
7.2.4 Johnson & Johnson Dermatology Drug Revenue in Global Market (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Dermatology Drug Major Product Offerings
7.3.4 Bayer Dermatology Drug Revenue in Global Market (2017-2022)
7.3.5 Bayer Key News
7.4 Galderma
7.4.1 Galderma Corporate Summary
7.4.2 Galderma Business Overview
7.4.3 Galderma Dermatology Drug Major Product Offerings
7.4.4 Galderma Dermatology Drug Revenue in Global Market (2017-2022)
7.4.5 Galderma Key News
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Corporate Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Dermatology Drug Major Product Offerings
7.5.4 Bristol-Myers Squibb Dermatology Drug Revenue in Global Market (2017-2022)
7.5.5 Bristol-Myers Squibb Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Dermatology Drug Major Product Offerings
7.6.4 Novartis Dermatology Drug Revenue in Global Market (2017-2022)
7.6.5 Novartis Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Dermatology Drug Major Product Offerings
7.7.4 Pfizer Dermatology Drug Revenue in Global Market (2017-2022)
7.7.5 Pfizer Key News
7.8 Merz Pharma
7.8.1 Merz Pharma Corporate Summary
7.8.2 Merz Pharma Business Overview
7.8.3 Merz Pharma Dermatology Drug Major Product Offerings
7.8.4 Merz Pharma Dermatology Drug Revenue in Global Market (2017-2022)
7.8.5 Merz Pharma Key News
7.9 Valeant
7.9.1 Valeant Corporate Summary
7.9.2 Valeant Business Overview
7.9.3 Valeant Dermatology Drug Major Product Offerings
7.9.4 Valeant Dermatology Drug Revenue in Global Market (2017-2022)
7.9.5 Valeant Key News
7.10 LEO Pharma
7.10.1 LEO Pharma Corporate Summary
7.10.2 LEO Pharma Business Overview
7.10.3 LEO Pharma Dermatology Drug Major Product Offerings
7.10.4 LEO Pharma Dermatology Drug Revenue in Global Market (2017-2022)
7.10.5 LEO Pharma Key News
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Corporate Summary
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Dermatology Drug Major Product Offerings
7.11.4 GlaxoSmithKline Dermatology Drug Revenue in Global Market (2017-2022)
7.11.5 GlaxoSmithKline Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Dermatology Drug Market Opportunities & Trends in Global Market
Table 2. Dermatology Drug Market Drivers in Global Market
Table 3. Dermatology Drug Market Restraints in Global Market
Table 4. Key Players of Dermatology Drug in Global Market
Table 5. Top Dermatology Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Dermatology Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Dermatology Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Dermatology Drug Product Type
Table 9. List of Global Tier 1 Dermatology Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatology Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Dermatology Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Dermatology Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Dermatology Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Dermatology Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Dermatology Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Dermatology Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Dermatology Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Dermatology Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Dermatology Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Dermatology Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Dermatology Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Dermatology Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Dermatology Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Dermatology Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Dermatology Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Dermatology Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Dermatology Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Dermatology Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Dermatology Drug Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Dermatology Drug Product Offerings
Table 32. AbbVie Dermatology Drug Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Dermatology Drug Product Offerings
Table 35. Johnson & Johnson Dermatology Drug Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Dermatology Drug Product Offerings
Table 38. Bayer Dermatology Drug Revenue (US$, Mn), (2017-2022)
Table 39. Galderma Corporate Summary
Table 40. Galderma Dermatology Drug Product Offerings
Table 41. Galderma Dermatology Drug Revenue (US$, Mn), (2017-2022)
Table 42. Bristol-Myers Squibb Corporate Summary
Table 43. Bristol-Myers Squibb Dermatology Drug Product Offerings
Table 44. Bristol-Myers Squibb Dermatology Drug Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Dermatology Drug Product Offerings
Table 47. Novartis Dermatology Drug Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Dermatology Drug Product Offerings
Table 50. Pfizer Dermatology Drug Revenue (US$, Mn), (2017-2022)
Table 51. Merz Pharma Corporate Summary
Table 52. Merz Pharma Dermatology Drug Product Offerings
Table 53. Merz Pharma Dermatology Drug Revenue (US$, Mn), (2017-2022)
Table 54. Valeant Corporate Summary
Table 55. Valeant Dermatology Drug Product Offerings
Table 56. Valeant Dermatology Drug Revenue (US$, Mn), (2017-2022)
Table 57. LEO Pharma Corporate Summary
Table 58. LEO Pharma Dermatology Drug Product Offerings
Table 59. LEO Pharma Dermatology Drug Revenue (US$, Mn), (2017-2022)
Table 60. GlaxoSmithKline Corporate Summary
Table 61. GlaxoSmithKline Dermatology Drug Product Offerings
Table 62. GlaxoSmithKline Dermatology Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Dermatology Drug Segment by Type in 2021
Figure 2. Dermatology Drug Segment by Application in 2021
Figure 3. Global Dermatology Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Dermatology Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dermatology Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dermatology Drug Revenue in 2021
Figure 8. By Type - Global Dermatology Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Dermatology Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Dermatology Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Dermatology Drug Revenue Market Share, 2017-2028
Figure 12. US Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Dermatology Drug Revenue Market Share, 2017-2028
Figure 16. Germany Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Dermatology Drug Revenue Market Share, 2017-2028
Figure 24. China Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Dermatology Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Dermatology Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Dermatology Drug Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Galderma Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bristol-Myers Squibb Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merz Pharma Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Valeant Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. LEO Pharma Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. GlaxoSmithKline Dermatology Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Dermatology Drug Market

Leave This Empty: